
Upfront Diagnostics Secures £1.6M Funding to Revolutionise Stroke Diagnosis
Upfront Diagnostics, a healthcare company focused on discovering novel biomarkers that can be applied to medical diagnosis, has announced a seed funding round of £1.6 million.














